TXG · Company research
10x Genomics, Inc. Class A Common Stock (TXG): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableTechnology
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 80.66 | $11,551,335,416.12 | 11061050416.12 | — | — | — | 76.5785314275107231 | 14.1851835585344408 | 471.04087656975084613378 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.